Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13718-13727
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13718
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13718
AJCC 6th | AJCC 7th | ||
T1 | Tumour invades lamina propria or submucosa | T1a | Invades Lamina propria or muscularis mucosae |
T1b | Invades Submucosa | ||
T2a | Invades Muscularis propria | T2 | Invades Muscularis propria |
T2b | Invades Subserosa | ||
T3 | Penetrates Serosa (visceral peritoneum), without invasion of adjacent structures | T3 | Penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures |
T4 | Invades adjacent structures | T4a | Tumor invades serosa (visceral peritoneum) |
T4b | Tumor invades adjacent structures | ||
N1 | 1-6 nodes involved | N1 | 1-2 nodes involved |
N2 | 7-15 nodes involved | N2 | 3-6 nodes involved |
N3 | > 15 nodes involved | N3a | 7-15 nodes involved |
N3b | > 15 nodes involved |
- Citation: Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13718.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13718